C. Behrens

发表

PNA hybridizes to complementary oligonucleotides obeying the WatsonCrick hydrogen-bonding rules

Peter E. Nielsen, Carsten Behrens, Rolf H. Berg, 1993, Nature.

Small-molecule agonists for the glucagon-like peptide 1 receptor

Jeppe Sturis, Jarek Kostrowicki, Carsten Behrens, 2007, Proceedings of the National Academy of Sciences.

Extended Target Sequence Specificity of PNA–Minor‐Groove Binder Conjugates

P. Nielsen, C. Behrens, K. Frederiksen, 2005, Chembiochem : a European journal of chemical biology.

New β-Alanine Derivatives Are Orally Available Glucagon Receptor Antagonists

C. Behrens, L. B. Knudsen, C. L. Brand, 2007 .

Long-Acting Human Growth Hormone Analogue by Noncovalent Albumin Binding.

C. Behrens, J. Fels, P. Thygesen, 2018, Bioconjugate chemistry.

Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor.

J. Holst, J. D. de Jong, Michael D. Johnson, 2007, Bioorganic & medicinal chemistry letters.

Peptide nucleic acids containing adenine or guanine recognize thymine and cytosine in complementary DNA sequences

R. H. Berg, M. Egholm, P. Nielsen, 1993 .

New beta-alanine derivatives are orally available glucagon receptor antagonists.

C. Behrens, L. B. Knudsen, C. L. Brand, 2007, Journal of medicinal chemistry.

Fluorine-18 labelled aldehydes as prosthetic groups for oxime coupling with a FVIIa protein.

C. Behrens, A. Kjaer, J. Madsen, 2020, Journal of labelled compounds & radiopharmaceuticals.

Characterization of pp64, a nuclear phosphoprotein induced by platelet-derived growth factor.

C. Behrens, T. Deuel, L. Shawver, 1989, Biochemical and biophysical research communications.

Investigating clearance mechanisms for recombinant activated factor VII in a perfused liver model

C. Behrens, M. S. Christensen, N. K. Klausen, 2010, Thrombosis and Haemostasis.

Oxime Coupling of Active Site Inhibited Factor Seven with a Nonvolatile, Water-Soluble Fluorine-18 Labeled Aldehyde.

C. H. Nielsen, C. Behrens, A. Kjaer, 2019, Bioconjugate chemistry.

Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.

C. Behrens, L. B. Knudsen, E. Nishimura, 2009, Journal of medicinal chemistry.

Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor.

C. Behrens, L. B. Knudsen, E. Nishimura, 2008, Journal of medicinal chemistry.

High‐affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats

C. Behrens, C. Øie, K. Roepstorff, 2016, Journal of thrombosis and haemostasis : JTH.

Synthesis of achiral linker reagents for direct labelling of oligonucleotides on solid supports.

C. Behrens, O. Dahl, 1999, Nucleosides & nucleotides.

Sialyltransferase-mediated glycoPEGylation

C. Behrens, J. Buchardt, 2020 .

Synthesis of Peptide Nucleic Acid Monomers Containing the Four Natural Nucleobases: Thymine, Cytosine, Adenine, and Guanine and Their Oligomerization

R. H. Berg, M. Egholm, P. Nielsen, 1994 .

Crystal and molecular structures of .pi.-toluene complexes of bis(pentafluorobenzene)cobalt and bis(pentafluorobenzene)nickel

K. Klabunde, C. Behrens, B. B. Anderson, 1980 .

CRYSTAL AND MOLECULAR STRUCTURES OF Π-TOLUENE COMPLEXES OF BIS(PENTAFLUOROBENZENE)COBALT AND BIS(PENTAFLUOROBENZENE)NICKEL

K. Klabunde, C. Behrens, B. B. Anderson, 1980 .

Synthesis of a Hoechst 32258 analogue amino acid building block for direct incorporation of a fluorescent, high-affinity DNA binding motif into peptides.

P. Nielsen, C. Behrens, N. Harrit, 2001, Bioconjugate chemistry.

A New Achiral Reagent for the Incorporation of Multiple Amino Groups into Oligonucleotides.

M. Egholm, O. Buchardt, C. Behrens, 1995 .

A new achiral linker reagent for the incorporation of multiple amino groups into oligonucleotides

M. Egholm, C. Behrens, J. Nielsen, 1995 .

Development of Strategies for the Site-Specific In Vivo Incorporation of Photoreactive Amino Acids: p-Azidophenylalanine, p-Acetylphenylalanine and Benzofuranylalanine

P. Nielsen, C. Behrens, M. Ibba, 2000 .

N‐Benzyl‐2,3‐Azetidinedione

C. Behrens, L. Paquette, 2003 .

N-BENZYL-2,3-AZETIDINEDIONE : (2,3-AZETIDINEDIONE, 1-(PHENYLMETHYL)-)

C. Behrens, L. Paquette, 1998 .

Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone.

H. Andersen, C. Behrens, J. Fels, 2017, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Glycoprotein labeling using engineered variants of galactose oxidase obtained by directed evolution.

Nicholas J Turner, Carsten Behrens, C. Behrens, 2010, Journal of the American Chemical Society.

Engineered CHO cells for production of diverse, homogeneous glycoproteins

Claus Kristensen, Shamim H Rahman, Carsten Behrens, 2015, Nature Biotechnology.

Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry.

C. H. Nielsen, C. Behrens, A. Kjaer, 2017, Bioconjugate chemistry.